Can rodent models of diabetic kidney disease clarify the significance of early hyperfiltration?: Recognizing clinical and experimental uncertainties

Clinical Science

Volumn 114, Issue 1-2, 2008, Pages 109-118

  Levine, David Z ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Diabetes mellitus; Diabetic nephropathy; Glomerular filtration rate; Hyperfiltration; Nitric oxide; Rodent model

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR; NITRIC OXIDE SYNTHASE;

DIABETIC NEPHROPATHY; GLOMERULUS FILTRATION RATE; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY TUMOR; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; ULTRAFILTRATION; ANIMAL; DISEASE MODEL; GLOMERULUS; KIDNEY; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; RODENT;

ANIMALS; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; GLOMERULAR FILTRATION RATE; KIDNEY; KIDNEY GLOMERULUS; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RODENTIA;

EID: 38349054364     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20070088     Document Type: Review

References (95)

1. Hostetter, T. H., Olson, J. L., Rennke, H. G., Venkatachalam, M. A. and Brenner, B. M. (2001) Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. J. Am. Soc. Nephrol. 12, 1315-1325
2. Brenner, B. M., Hostetter, T. H., Olson, J. L., Rennke, H. G. and Venkatachalam, M. A. (1981) The role of glomerular hyperfiltration in the initiation and progression of diabetic nephropathy. Acta Endocrinol. 242, 7-10
3. Anderson, S. and Brenner, B. M. (1988) Role of altered capillary hemodynamics in the initiation and progression of diabetic microangiopathy. J. Diabetic Complications 2, 59-61
4. Zatz, R., Dunn, B. R., Meyer, T. W., Anderson, S., Rennke, H. G. and Brenner, B. M. (1986) Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J. Clin. Invest. 77, 1925-1930
5. Remuzzi, G., Benigni, A. and Remuzzi, A. (2006) Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J. Clin. Invest. 116, 288-296
6. Caramori, M. L., Fioretto, P. and Mauer, M. (2006) Enhancing the predictive value of urinary albumin for diabetic nephropathy. J. Am. Soc. Nephrol. 17, 339-352
7. (2005) American Society of Nephrology Renal Research Report. J. Am. Soc. Nephrol. 16, 1886-1903
8. Schnermann, J. and Levine, D. Z. (2003) Paracrine factors in tubuloglomerular feedback: adenosine, ATP, and nitric oxide. Annu. Rev. Physiol. 65, 501-529
9. Levine, D. Z. (2006) Hyperfiltration, nitric oxide, and diabetic nephropathy. Curr. Hypertens. Rep. 8, 153-157
10. Qi, Z., Fujita, H., Jin, J. et al. (2005) Characterization of susceptibility of inbred mouse strains to diabetic nephropathy. Diabetes 54, 2628-2637
11. Breyer, M. D., Bottinger, E., Brosius, F. C. et al. (2005) Diabetic nephropathy: of mice and men. Adv. Chronic Kidney Dis. 12, 128-145
12. Levine, D. Z., Iacovitti, M., Robertson, S. J. and Mokhtar, G. A. (2006) Modulation of single-nephron GFR in the db/db mouse model of type 2 diabetes mellitus. Am. J. Physiol. Renal Physiol. 290, R975-R981
13. Drummond, K. and Mauer, M. (2002) The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes 51, 1580-1587
14. Nowack, R., Raum, E., Blum, W. and Ritz, E. (1992) Renal hemodynamics in recent-onset type II diabetes. Am. J. Kidney Dis. 20, 342-347
15. Rudberg, S., Osterby, R., Dahlquist, G., Nyberg, G. and Persson, B. (1997) Predictors of renal morphological changes in the early stage of microalbuminuria in adolescents with IDDM. Diabetes Care 20, 265-271
16. Steinke, J. M., Sinaiko, A. R., Kramer, M. S., Suissa, S., Chavers, B. M. and Mauer, M. (2005) The early natural history of nephropathy in Type 1 diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes 54, 2164-2171
17. Chaiken, R. L., Eckert-Norton, M., Bard, M. et al. (1998) Hyperfiltration in African-American patients with type 2 diabetes. Cross-sectional and longitudinal data. Diabetes Care 21, 2129-2134
18. Parving, H. H., Mauer, M. and Ritz, E. (2004) Diabetic nephropathy. The Kidney, 7th edn (Brenner, M. D., ed.), pp. 1777-1818, Saunders, Philadelphia
19. Mogensen, C. E. (1986) Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. Scand. J. Clin. Lab. Invest. 46, 201-206
20. Rudberg, S., Persson, B. and Dahlquist, G. (1992) Increased glomerular filtration rate as a predictor of diabetic nephropathy: an 8-year prospective study. Kidney Int. 41, 822-828
21. Rossing, P., Hougaard, P. and Parving, H. H. (2002) Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. Diabetes Care 25, 859-864
22. Jones, S. L., Wiseman, M. J. and Viberti, G. C. (1991) Glomerular hyperfiltration as a risk factor for diabetic nephropathy: five-year report of a prospective study. Diabetologia 34, 59-60
23. Lervang, H. H., Jensen, S., Brochner-Mortensen, J. and Ditzel, J. (1988) Early glomerular hyperfiltration and the development of late nephropathy in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 31, 723-729
24. Vedel, P., Obel, J., Nielsen, F. S. et al. (1996) Glomerular hyperfiltration in microalbuminuric NIDDM patients. Diabetologia 39, 1584-1589
25. Nelson, R. G., Bennett, P. H., Beck, G. J. et al. (1996) Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N. Engl. J. Med. 335, 1636-1642
26. Nenov, V. D., Taal, M. W., Sakharova, O. V. and Brenner, B. M. (2000) Multi-hit nature of chronic renal disease. Curr. Opin. Nephrol. Hypertens. 9, 85-97
27. Taal, M. W. and Brenner, B. M. (2006) Predicting initiation and progression of chronic kidney disease: developing renal risk scores. Kidney Int. 70, 1694-1705
28. Levine, D. Z., Iacovitti, M. and Burns, K. D. (2000) Distal tubule bicarbonate reabsorption in intact and remnant diabetic kidneys. Kidney Int. 57, 544-549
29. Mozaffari, M. S., Warren, B. K., Russell, C. M. and Schaffer, S. W. (1997) Renal function in the noninsulin-dependent diabetic rat: effects of unilateral nephrectomy. J. Pharmacol. Toxicol. Methods 37, 197-203
30. Maeda, M., Yabuki, A., Suzuki, S., Matsumoto, M., Taniguchi, K. and Nishinakagawa, H. (2003) Renal lesions in spontaneous insulin-dependent diabetes mellitus in the nonobese diabetic mouse: acute phase of diabetes. Vet. Pathol. 40, 187-195
31. Lubec, B., Hermon, M., Hoeger, H. and Lubec, G. (1998) Aromatic hydroxylation in animal models of diabetes mellitus. FASEB J. 12, 1581-1587
32. Palm, F., Ortsater, H., Hansell, P., Liss, P. and Carlsson, P. O. (2004) Differentiating between effects of streptozotocin per se and subsequent hyperglycemia on renal function and metabolism in the streptozotocin-diabetic rat model. Diabetes Metab. Res. Rev. 20, 452-459
33. Hartner, A., Cordasic, N., Klanke, B., Wittmann, M., Veelken, R. and Hilgers, K. F. (2007) Renal injury in streptozotocin-diabetic Ren2-transgenic rats is mainly dependent on hypertension, not on diabetes. Am. J. Physiol. Renal Physiol. 292, F820-F827
34. Hartner, A., Veelken, R., Wittmann, M., Cordasic, N. and Hilgers, K. F. (2005) Effects of diabetes and hypertension on macrophage infiltration and matrix expansion in the rat kidney. BMC Nephrology 6, 6
35. Veelken, R., Hilgers, K. F., Hartner, A., Haas, A., Bohmer, K. P. and Sterzel, R. B. (2000) Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. J. Am. Soc. Nephrol. 11, 71-79
36. Imaeda, A., Kaneko, T., Aoki, T., Kondo, Y. and Nagase, H. (2002) DNA damage and the effect of antioxidants in streptozotocin-treated mice. Food Chem. Toxicol. 40, 979-987
37. Breyer, M. D., Bottinger, E., Brosius, III, F. C. et al. (2005) Mouse models of diabetic nephropathy. J. Am. Soc. Nephrol. 16, 27-45
38. Breyer, M. D., Qi, Z. and Tchekneva, E. (2006) Diabetic nephropathy: leveraging mouse genetics. Curr. Opin. Nephrol. Hypertens. 15, 227-232
39. Gartner, K. (1978) Glomerular hyperfiltration during the onset of diabetes mellitus in two strains of diabetic mice (c57bl/6j db/db and c57bl/ksj db/db). Diabetologia 15, 59-63
40. Zhao, H. J., Wang, S., Cheng, H. et al. (2006) Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J. Am. Soc. Nephrol. 17, 2664-2669
41. Nakagawa, T., Sato, W., Glushakova, O. et al. (2007) Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J. Am. Soc. Nephrol. 18, 539-550
42. Braam, B. (1999) Renal endothelial and macula densa NOS: integrated response to changes in extracellular fluid volume. Am. J. Physiol. 276, R1551-R1561
43. Komers, R. and Anderson, S. (2003) Paradoxes of nitric oxide in the diabetic kidney. Am. J. Physiol. Renal Physiol. 284, F1121-F1137
44. Prabhakar, S. S. (2004) Role of nitric oxide in diabetic nephropathy. Semin. Nephrol. 24, 333-344
45. Wilcox, C. (2000) L-Arginine-Nitric Oxide Pathway, Lippincott Williams & Wilkins, Philadelphia
46. Wilcox, C. S., Welch, W. J., Murad, F. et al. (1992) Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc. Natl. Acad. Sci. U.S.A. 89, 11993-11997
47. Komers, R., Oyama, T. T., Chapman, J. G., Allison, K. M. and Anderson, S. (2000) Effects of systemic inhibition of neuronal nitric oxide synthase in diabetic rats. Hypertension 35, 655-661
48. Erdely, A., Freshour, G., Maddox, D. A., Olson, J. L., Samsell, L. and Baylis, C. (2004) Renal disease in rats with type 2 diabetes is associated with decreased renal nitric oxide production. Diabetologia 47, 1672-1676
49. Suto, T., Losonczy, G., Qiu, C. et al. (1995) Acute changes in urinary excretion of nitrite+nitrate do not necessarily predict renal vascular NO production. Kidney Int. 48, 1272-1277
50. Weight, S. C. and Nicholson, M. L. (1998) Nitric oxide and renal reperfusion injury: a review. Eur. J. Vasc. Endovasc. Surg. 16, 98-103
51. Kovacs, G., Komlosi, P., Fuson, A., Peti-Peterdi, J., Rosivall, L. and Bell, P. D. (2003) Neuronal nitric oxide synthase: its role and regulation in macula densa cells. J. Am. Soc. Nephrol. 14, 2475-2483
52. Wilcox, C. S. and Welch, W. J. (2000) Interaction between nitric oxide and oxygen radicals in regulation of tubuloglomerular feedback. Acta Physiol. Scand. 168, 119-124
53. Levine, D. Z. and Iacovitti, M. (2002) Nitric oxide [NO] concentrations in distal tubular fluid are modulated in vivo by loop perfusion of NaCl in normal and diabetic rats, Proc. Can. Soc. Nephrol. Abstract #55
54. Levine, D. Z. and Iacovitti, M. (2006) Real-time measurement of kidney tubule fluid nitric oxide concentrations in early diabetes: disparate changes in different rodent models. Nitric Oxide 15, 87-92
55. Levine, D. Z., Iacovitti, M., Burns, K. D. and Zhang, X. (2001) Real-time profiling of kidney tubular fluid nitric oxide concentrations in vivo. Am. J. Physiol. Renal Physiol. 281, F189-F194
56. Luiking, Y. C., Hallemeesch, M. M., Vissers, Y. L., Lamers, W. H. and Deutz, N. E. (2004) In vivo whole body and organ arginine metabolism during endotoxemia (sepsis) is dependent on mouse strain and gender. J. Nutr. 134, 2768S-2774S
57. Holscher, C. (2002) Different strains of rats show different sensitivity to block of long-term potentiation by nitric oxide synthase inhibitors. Eur. J. Pharmacol. 457, 99-106
58. Ortiz, P. A. and Garvin, J. L. (2003) Trafficking and activation of eNOS in epithelial cells. Acta Physiol. Scand. 179, 107-114
59. Wang, H., Carretero, O. A. and Garvin, J. L. (2002) Nitric oxide produced by THAL nitric oxide synthase inhibits TGF. Hypertension 39, 662-666
60. Gschwend, S., Buikema, H., Navis, G., Henning, R. H., de Zeeuw, D. and van Dokkum, R. P. (2002) Endothelial dilatory function predicts individual susceptibility to renal damage in the 5/6 nephrectomized rat. J. Am. Soc. Nephrol. 13, 2909-2915
61. Modlinger, P. S., Wilcox, C. S. and Aslam, S. (2004) Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin. Nephrol. 24, 354-365
62. Reyes, A. A., Karl, I. E., Kissane, J. and Klahr, S. (1993) L-Arginine administration prevents glomerular hyperfiltration and decreases proteinuria in diabetic rats. J. Am. Soc. Nephrol. 4, 1039-1045
63. Vallon, V., Traynor, T., Barajas, L., Huang, Y. G., Briggs, J. P. and Schnermann, J. (2001) Feedback control of glomerular vascular tone in neuronal nitric oxide synthase knockout mice. J. Am. Soc. Nephrol. 12, 1599-1606
64. Vallon, V., Richter, K., Blantz, R. C., Thomson, S. and Osswald, H. (1999) Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption. J. Am. Soc. Nephrol. 10, 2569-2576
65. Thomson, S. C., Deng, A., Bao, D., Satriano, J., Blantz, R. C. and Vallon, V. (2001) Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes. J. Clin. Invest. 107, 217-224
66. Vallon, V., Blantz, R. C. and Thomson, S. (1995) Homeostatic efficiency of tubuloglomerular feedback is reduced in established diabetes mellitus in rats. Am. J. Physiol. 269, F876-F883
67. Vallon, V., Kirschenmann, D., Wead, L. M. et al. (1997) Effect of chronic salt loading on kidney function in early and established diabetes mellitus in rats. J. Lab. Clin. Med. 130, 76-82
68. Miller, J. A. (1997) Renal responses to sodium restriction in patients with early diabetes mellitus. J. Am. Soc. Nephrol. 8, 749-755
69. Allen, T. J., Waldron, M. J., Casley, D., Jerums, G. and Cooper, M. E. (1997) Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes. Diabetes 46, 19-24
70. Bank, N., Lahorra, G., Aynedjian, H. S. and Wilkes, B. M. (1988) Sodium restriction corrects hyperfiltration of diabetes. Am. J. Physiol. 254, F668-F676
71. Persson, A. E., Gutierrez, A., Pittner, J. et al. (2000) Renal NO production and the development of hypertension. Acta Physiol. Scand. 168, 169-174
72. Komers, R., Lindsley, J. N., Oyama, T. T., Allison, K. M. and Anderson, S. (2000) Role of neuronal nitric oxide synthase (NOS1) in the pathogenesis of renal hemodynamic changes in diabetes. Am. J. Physiol. Renal Physiol. 279, F573-F583
73. Maree, A., Peer, G., Iaina, A. et al. (1996) Nitric oxide in streptozotocin-induced diabetes mellitus in rats. Clin. Sci. 90, 379-384
74. Mattar, A. L., Fujihara, C. K., Ribeiro, M. O., de Nucci, G. and Zatz, R. (1996) Renal effects of acute and chronic nitric oxide inhibition in experimental diabetes. Nephron 74, 136-143
75. Goligorsky, M. S. (2000) Endothelial cell dysfunction and nitric oxide synthase. Kidney Int. 58, 1360-1376
76. Ishii, N., Patel, K. P., Lane, P. H. et al. (2001) Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J. Am. Soc. Nephrol. 12, 1630-1639
77. Schnackenberg, C. G. (2002) Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. Am. J. Physiol. Renal Physiol. 282, R335-R342
78. Loutzenhiser, R., Griffin, K., Williamson, G. and Bidani, A. (2006) Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am. J. Physiol. Renal Physiol. 290, R1153-R1167
79. Hayashi, K., Epstein, M., Loutzenhiser, R. and Forster, H. (1992) Impaired myogenic responsiveness of the afferent arteriole in streptozotocin-induced diabetic rats: role of eicosanoid derangements. J. Am. Soc. Nephrol. 2, 1578-1586
80. +-ATPase. Am. J. Physiol. 272, F799-F808
81. Levine, D. Z., Iacovitti, M. and Harrison, V. (1991) Bicarbonate secretion in vivo by rat distal tubules during alkalosis induced by dietary chloride restriction and alkali loading. J. Clin. Invest. 87, 1513-1518
82. Blantz, R. C., Gabbai, F. B., Peterson, O. W. and Thomson, S. C. (1991) Tubuloglomerular feedback activity after acute reductions in renal mass. Kidney Int. Suppl. 32, S102-S105
83. Salmond, R. and Seney, F. J. (1991) Reset tubuloglomerular feedback permits and sustains glomerular hyperfunction after extensive renal ablation. Am. J. Physiol. Renal Physiol. 260, F395-F401
84. Aiello, S., Noris, M., Todeschini, M. et al. (1997) Renal and systemic nitric oxide synthesis in rats with renal mass reduction. Kidney Int. 52, 171-181
85. Roczniak, A., Fryer, J. N., Levine, D. Z. and Burns, K. D. (1999) Downregulation of neuronal nitric oxide synthase in the rat remnant kidney. J. Am. Soc. Nephrol. 10, 704-713
86. Levine, D. Z. and Iacovitti, M. (2006) Effect of reduction in renal mass and nNOS inhibition on single nephron GFR and tubuloglomerular feedback in the db/db mouse model of type 2 diabetes mellitus. J. Am. Soc. Nephrol. 17, 122A-123A
87. Quaggin, S. E. and Coffman, T. M. (2007) Toward a mouse model of diabetic nephropathy: is endothelial nitric oxide synthase the missing link? J. Am. Soc. Nephrol. 18, 364-366
88. Wilcox, C. S. (1998) Role of macula densa NOS in tubuloglomerular feedback. Curr. Opin. Nephrol. Hypertens. 7, 443-449
89. Wilcox, C. S. and Welch, W. J. (1998) Macula densa nitric oxide synthase: expression, regulation, and function. Kidney Int. Suppl. 67, S53-S57
90. Pistrosch, F., Herbrig, K., Kindel, B., Passauer, J., Fischer, S. and Gross, P. (2005) Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients. Diabetes 54, 2206-2211
91. Arima, S., Kohagura, K., Takeuchi, K. et al. (2002) Biphasic vasodilator action of troglitazone on the renal microcirculation. J. Am. Soc. Nephrol. 13, 342-349
92. Isshiki, K., Haneda, M., Koya, D., Maeda, S., Sugimoto, T. and Kikkawa, R. (2000) Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats. Diabetes 49, 1022-1032
93. Patzak, A., Kleinmann, F., Lai, E. Y., Kupsch, E., Skelweit, A. and Mrowka, R. (2004) Nitric oxide counteracts angiotensin II induced contraction in efferent arterioles in mice. Acta Physiol. Scand. 181, 439-444
94. Zatz, R., Meyer, T. W., Rennke, H. G. and Brenner, B. M. (1985) Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc. Natl. Acad. Sci. U.S.A. 82, 5963-5967
95. Sharma, K., McCue, P. and Dunn, S. R. (2003) Diabetic kidney disease in the db/db mouse. Am. J. Physiol. Renal Physiol. 284, F1138-F1144